Clinical trial
Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy
NCT00242606 · Philipps University Marburg, Other · Completed
Key facts
| NCT number | NCT00242606 |
|---|---|
| Title | Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy |
| Official title | Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy: An Open, Prospective, Multicenter, Randomized Phase III Study |
| Lead sponsor | Philipps University Marburg, Other |
| Collaborators | UCB Pharma GmbH Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Epilepsy |
| Intervention type | Drug |
| Interventions | Lamotrigine, Levetiracetam |
| Enrollment | 409 |
| Start date | Mar 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | Jan 1, 2009 |
| First posted | Oct 20, 2005 |
| Last update posted | May 9, 2012 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: